Intraocular ophthalmic irrigation maintains the natural anatomic and physiologic integrity of eye. Intraocular ophthalmic irrigation finds applications in ophthalmic surgical procedures of the eye as well as to relieve symptoms of eye injury caused by chemicals or allergens. Intraocular irrigation solutions are formulated with chemical composition similar to secretions of the eye to achieve physiological pH of the eye to minimize eye discomfort. These are the first choice of treatment for exposure to irritant chemicals or removal of foreign particles from the eye. Acids and alkalis exposure results in severe eye damage and requires immediate medical intervention. Chemical injuries to the eye can result in temporary or permanent visual impairment. Early treatment can reduce the complications and prevent blindness. Chemical injuries to eye are generally caused at workplace, home, or as a result of criminal attacks. Occupational exposure to the chemicals is a leading cause of eye damage. Out of the total ocular trauma cases, about 20% are caused due to chemical injury.
Increasing industrialization, growing chemical, pharma, biotech, and agricultural industries; and increasing number of employees working in these industries are driving The Intraocular Irrigation Solutions Market. According to NCBI, industrial accidents account for 61% of ocular chemical burns. Young children also become victims of accidental exposure to household chemicals. Apart from this, increasing cases of ophthalmic surgeries performed with the help of local anesthesia given in the form of intraocular irrigation solutions is expected to boost the growth of the intraocular irrigation solutions market during the forecast period.
Request to View Brochure of Report –
Key players operating in the global intraocular irrigation solution market are Novartis AG, Regulatory Pharma Net s.r.l., Bausch + Lomb UK Limited, ALBOMED GmbH, Omeros Corporation, Carl Zeiss, Meditec AG, Omni Lens Pvt. Ltd., Heil Pharma, Cytosol Ophthalmics, and PREVOR, among others.